Publication | Closed Access

Hexachlorophene, a selective SHP2 inhibitor, suppresses proliferation and metastasis of KRAS-mutant NSCLC cells by inhibiting RAS/MEK/ERK and PI3K/AKT signaling pathways

Signal TransductionKras-mutant Nsclc CellsSignaling PathwayCell RegulationMedicineReceptor Tyrosine KinaseSelective Shp2 InhibitorPi3k/akt Signaling PathwaysTumor SuppressorRadiation OncologyCancer BiologyCell BiologyCell SignalingTumor Biology